Bayer and NUS Enterprise announce winners of Grants4Apps Singapore Open Innovation Challenge
By Digital News Asia May 4, 2017
- Grants4Apps programme fosters digital and technological innovations in healthcare globally
- Winners to receive US$7,170 each, access to mentorships, incubator space, and networks
BAYER and NUS Enterprise, the entrepreneurial arm of the National University of Singapore (NUS), on May 3 announced three winners from 80 applications of the inaugural round of Grants4Apps Singapore, a web-based crowdsourcing initiative that calls for innovative health-tech solutions to improve medication adherence in elderly people with chronic diseases across Asia Pacific.
The three teams of winners are from Singapore and Thailand.
Grants4Apps Singapore is part of Bayer’s global Grants4Apps programme that supports innovators for their health-tech ideas which contribute to improvements in health outcomes or pharmaceutical processes.
The first round of the challenge was jointly launched by Bayer and NUS Enterprise on Dec 1, 2016 at the Transforming Aging with Health Innovation Forum, officiated by Dr Amy Khor, Senior Minister of State for Ministry of Health, Singapore.
The crowdsourcing initiative closed on March 31, 2017 with a total of 80 applications from countries including Singapore, Thailand, India, Australia, Taiwan, S. Korea, and the Philippines.
“Our Grants4Apps programme fosters digital and technological innovations in healthcare globally. We are impressed by the wealth of ideas and the high quality of our finalists from this regional chapter of our programme which focuses on finding solutions to improve medication adherence in our rapidly aging population,” said Kemal Malik, Member of the Board of Management, responsible for Innovation at Bayer, as he gave out the awards to the three winning teams.
“Some of these concepts have the potential to benefit patients, doctors and consumers, revolutionising healthcare delivery and improving treatment results. We are delighted to support the winners in advancing their innovative ideas.”
After an evaluation of the applications, six finalist teams were selected for coaching and mentorship followed by a final round of pitching and an awards ceremony, held on May 3 at Innovfest Unbound, an anchor event of Singapore’s Smart Nation Innovations week 2017 featuring Asia’ most innovative developments.
The winners of Grants4Apps Singapore are:
EyeDEA, Singapore: A two-in-one card and wearable that improves elderly glaucoma patients’ compliance to eye drops. A personalised wallet-size medication card improves patients’ understanding and recall of medication regimes, while a customised wearable with an alarm reminds and tracks glaucoma patients’ usage of eye drops.
The device targets elderly glaucoma patients in Singapore who typically do not own smartphones and have poor vision, which limits their ability to effectively use mobile applications with typically small font sizes.
Glycoleap by Holmusk, Singapore: An application (app) that monitors diabetes patients’ food habits, glucose readings, activity levels, weight and medicine adherence on a daily basis. As it monitors glucose level of patients daily, dieticians are able to ascertain if a patient has forgotten to take his/her medication.
Through the use of both technology and human intervention, the application helps to overcome the barriers of medication adherence.
PillPocket, Thailand: An integrated solution that provides personal healthcare assistance from pharmacists for patients with high blood pressure, high blood cholesterol and diabetes. PillPocket comprises a chatbot linked to pharmacist services such as follow-up care, supporting medication refill and home delivery and even free patient case management.
PillPocket also has a medication reminder function which triggers alerts via chat.
Other finalists of Grants4Apps Singapore are:
Pill-E, Singapore: A smart pill box integrated with an intuitive application that helps caregivers and patients to simplify and adhere to complex medication with ease. The intelligent application logs dosing pattern and adherence which can be shared with the doctor for assessment. Additional in-built mechanisms also prevent medication misuse. While differentiating from a normal pill box with its “smart” functions, Pill-e also offers a more affordable and convenient option to a pill dispenser.
Onward Health, India: A software which helps postoperative patients follow their discharge instructions and doctor’s advice, including physiotherapy, medication adherence and other vital parameters needed to be tracked. It helps patients stay connected to their post-operative care network through a simple communication platform enabling hospitals and doctors to keep track of their patients’ health after discharge. A dashboard also provides a view of the patient’s compliance as well as real-time health status.
A panel of judges from Bayer, NUS Enterprise and the industry evaluated the applications based on originality and practicality; the teams should be able to develop their proposed innovative concepts into minimum viable products in about six months to improve medication adherence in elderly people with chronic diseases.
There were no restrictions on platforms, operating systems and/or technologies.
“We are honoured to partner with Bayer on the Singapore edition of Grants4Apps focusing on medication adherence. We were impressed with the quality of submissions received, and we believe the ideas and innovations presented today will help create lasting social impact amongst the senior community in Singapore, the region and beyond,” said Lily Chan, CEO of NUS Entreprise, who was also part of the judging panel for Grants4Apps Singapore.
Each winning team will receive an award of US$7,170 (S$10,000) and access to mentorships and a global and regional network from Bayer, NUS and other industry partners to refine and scale their project.
The teams will also be eligible for incubator support from NUS Enterprise as well as access to the Modern Aging Singapore business accelerator programme, organised by ACCESS Health international and NUS Enterprise.
They may also be admitted to the global Grants4Apps programme and the Grants4App Accelerator and stand a chance to receive additional financial support, mentorships by Bayer managers and an international network of external entrepreneurs as well as co-working space at the global headquarters of Bayer Pharmaceuticals division in Berlin, Germany.
DoctorOnCall aims to grow to the next level
41% of APeJ healthcare organisations plan to launch IoT solutions in the next two years: IDC
BookDoc aims to break even this year
Reimagining healthcare services with GetDoc